https://www.gosh.nhs.uk/news/launching-our-patient-safety-incident-reporting-plan-psirp/
Launching our Patient Safety Incident Reporting Plan (PSIRP)
20 Feb 2024, 4 p.m.
GOSH has launched its new Patient Safety Incident Reporting Plan (PSIRP).
This plan outlines how we as an organisation will look at patient safety incidents, what tools will be used to investigate and how it will share and embed learning into everyday work.
The plan's objective
PSIRP forms part of the national Patient Safety Incident Response Framework (PSIRF), introduced by NHS England, which removes the requirement that only incidents meeting the criteria of a “serious incident” are investigated.
There will be greater engagement with those affected by safety events, including patients, families and colleagues, ensuring that they are treated with compassion and able to be part of an investigation.
Shona Little, Head of Patient Safety explains:
"PSIRF is about moving away from the idea of blaming one person or finding a single cause of something going wrong. We know that our colleagues come into work every day to give amazing care to our patients.
"This will help us make sure that if something does go wrong we have a greater set of tools to learn and embed new safety measures, with a focus on also learning from all of the excellent practice and care which is delivered every day in GOSH."
From staff idea to global innovation: Taking the next step towards improving patient safety
A simple idea developed by a GOSH clinician has secured a commercial partner.
Four research projects receive funding to improve understanding and treatment of childhood cancer
Researchers at Great Ormond Street Hospital (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have received funding from The Little Princess Trust for four childhood cancer research projects.
New study brings hope for children with rare life-threatening kidney disease
New research funded by Great Ormond Street Hospital Charity (GOSH Charity), LifeArc and Kidney Research UK has taken an important step towards developing a new treatment for serious genetic kidney diseases affecting children.